Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Yoshinori MORI"'
Autor:
Yoshinori Mori, Sandra G. Nishikawa, Andreea R. Fratiloiu, Mio Tsutsui, Hiromi Kataoka, Takashi Joh, Randal N. Johnston
Publikováno v:
Viruses, Vol 15, Iss 7, p 1472 (2023)
Patients with stage IV gastric cancer suffer from dismal outcomes, a challenge especially in many Asian populations and for which new therapeutic options are needed. To explore this issue, we used oncolytic reovirus in combination with currently used
Externí odkaz:
https://doaj.org/article/a9f1281c0356417f970fe3a3d5b6382a
Autor:
Hiroya Taniguchi, Keisuke Uehara, Goro Nakayama, Hiroshi Nakayama, Toshisada Aiba, Norifumi Hattori, Masato Kataoka, Yasuyuki Nakano, Yoshihisa Kawase, Osamu Okochi, Hiroshi Matsuoka, Setsuo Utsunomiya, Eiji Sakamoto, Yoshinori Mori, Shinichi Umeda, Toshio Shikano, Koji Komori, Masahiro Tajika, Shigenori Kadowaki, Kei Muro, Yasushi Yatabe
Publikováno v:
Translational Oncology, Vol 13, Iss 7, Pp 100786- (2020)
BACKGROUND: Primary tumor location is a critical prognostic factor that also impacts the efficacy of anti-epidermal growth factor receptor (EGFR) therapy in wild-type RAS (KRAS/NRAS) metastatic colorectal cancer (CRC). However, the association betwee
Externí odkaz:
https://doaj.org/article/ef4cda05f303454c8cea476dee81c494
Publikováno v:
Nihon Kikai Gakkai ronbunshu, Vol 85, Iss 880, Pp 19-00297-19-00297 (2019)
DLC (Diamond-Like Carbon) has excellent tribological properties such as high hardness, low friction and high wear resistance. It is widely applied in industrial field. In order to prevent excessive wear, DLC is also applied to the vane which is the m
Externí odkaz:
https://doaj.org/article/52ea709fc91545fcbbe675158e327a8c
Autor:
Tsutomu Mizoshita, Satoshi Tanida, Keiji Ozeki, Takahito Katano, Takaya Shimura, Yoshinori Mori, Eiji Kubota, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh
Publikováno v:
Case Reports in Gastroenterology, Vol 10, Iss 2, Pp 283-291 (2016)
There is little evidence regarding the maintenance of long-term clinical remission by adalimumab (ADA) therapy in Crohn’s disease (CD) patients naïve to anti-tumor necrosis factor treatment (naïve CD patients), since most CD patients are treated
Externí odkaz:
https://doaj.org/article/fae603fa085844d08f2f56af19996cc9
Autor:
Satoshi Tanida, Masaya Takemura, Tsutomu Mizoshita, Keiji Ozeki, Takahito Katano, Takaya Shimura, Yoshinori Mori, Eiji Kubota, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh
Publikováno v:
Case Reports in Gastrointestinal Medicine, Vol 2016 (2016)
A 64-year-old man with Crohn’s disease (CD) was admitted to our hospital due to moderate risk of pneumonia while receiving scheduled adalimumab maintenance therapy. Symptoms remained virtually unchanged following administration of antibiotics. A fi
Externí odkaz:
https://doaj.org/article/753e88b081f64b4ca90c31067b66ee9e
Autor:
Keiji Ozeki, Satoshi Tanida, Tsutomu Mizoshita, Hironobu Tsukamoto, Masahide Ebi, Yoshinori Mori, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh
Publikováno v:
Case Reports in Gastroenterology, Vol 6, Iss 3, Pp 765-771 (2012)
Adalimumab (ADA) is applied to induce remission in patients with Crohn’s disease (CD) naïve to chimeric anti-tumor necrosis factor-α (anti-TNF-α), infliximab or patients with loss of response to scheduled maintenance infliximab. Adsorptive granu
Externí odkaz:
https://doaj.org/article/754ab37974af4768a32ee66891586047
Publikováno v:
Viruses, Vol 10, Iss 8, p 421 (2018)
Oncolytic viruses show intriguing potential as cancer therapeutic agents. These viruses are capable of selectively targeting and killing cancerous cells while leaving healthy cells largely unaffected. The use of oncolytic viruses for cancer treatment
Externí odkaz:
https://doaj.org/article/ece0f7c7570a408e81b3fd24015c0f82
Autor:
Tsutomu Mizoshita, Satoshi Tanida, Hironobu Tsukamoto, Keiji Ozeki, Takahito Katano, Hirotaka Nishiwaki, Masahide Ebi, Yoshinori Mori, Eiji Kubota, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh
Publikováno v:
Gastroenterology Research and Practice, Vol 2014 (2014)
Background. Adalimumab (ADA) is effective for patients with Crohn’s disease (CD). However, there have been few reports on ADA therapy with respect to its relationship with pathologic findings and drug efficacy in biologically naïve CD cases. Metho
Externí odkaz:
https://doaj.org/article/431717d2363149bb9ba11fd4ac89dc4c
Autor:
Seira Owaki, Yoshinori Mori, Shunsuke Nakai, Hideki Maeda, Mitsuki Imazu, Yusaku Tomita, Hiroki Kanaiwa, Ayana Yamaguchi, Mika Kitagawa, Atsuyuki Hirano, Yoshihide Kimura, Kenji Tsuchida, Hiromi Kataoka
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 14, p1995-1999, 5p
Autor:
Johnston, Yoshinori Mori, Sandra G. Nishikawa, Andreea R. Fratiloiu, Mio Tsutsui, Hiromi Kataoka, Takashi Joh, Randal N.
Publikováno v:
Viruses; Volume 15; Issue 7; Pages: 1472
Patients with stage IV gastric cancer suffer from dismal outcomes, a challenge especially in many Asian populations and for which new therapeutic options are needed. To explore this issue, we used oncolytic reovirus in combination with currently used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::6af43408a85cba85a05680c26c07822d